ES2059507T3 - Moleculas biologicamente activas. - Google Patents

Moleculas biologicamente activas.

Info

Publication number
ES2059507T3
ES2059507T3 ES88302656T ES88302656T ES2059507T3 ES 2059507 T3 ES2059507 T3 ES 2059507T3 ES 88302656 T ES88302656 T ES 88302656T ES 88302656 T ES88302656 T ES 88302656T ES 2059507 T3 ES2059507 T3 ES 2059507T3
Authority
ES
Spain
Prior art keywords
biologically active
active molecules
angenic
reform
vertebrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88302656T
Other languages
English (en)
Inventor
Stephen James
Roger Aston
Robert Bomford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
S P Veterinary Ltd
Original Assignee
Pitman Moore Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitman Moore Ltd filed Critical Pitman Moore Ltd
Application granted granted Critical
Publication of ES2059507T3 publication Critical patent/ES2059507T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN PEPTIDO CON HOMOLOGIA ESTRUCTURAL PRIMARIA A UNA SECUENCIA CONTINUA DE RESIDUOS DE AMINOACIDOS DE HORMONA DE CRECIMIENTO EN LAS POSICIONES 35 A 53 O PEPTIDOS EQUIVALENTES ANTIGENICAMENTE A ESTE O SUS SALES, PUEDEN USARSE EN UNA FORMULACION ANTIGENICA PARA REFORZAR LOS EFECTOS DE LA HORMONA DEL CRECIMIENTO EN UN VERTEBRADO.
ES88302656T 1987-03-27 1988-03-25 Moleculas biologicamente activas. Expired - Lifetime ES2059507T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878707398A GB8707398D0 (en) 1987-03-27 1987-03-27 Biologically active molecules

Publications (1)

Publication Number Publication Date
ES2059507T3 true ES2059507T3 (es) 1994-11-16

Family

ID=10614804

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88302656T Expired - Lifetime ES2059507T3 (es) 1987-03-27 1988-03-25 Moleculas biologicamente activas.

Country Status (18)

Country Link
EP (1) EP0284406B1 (es)
JP (1) JP2926594B2 (es)
KR (1) KR0134117B1 (es)
AT (1) ATE111483T1 (es)
AU (1) AU622858B2 (es)
BR (1) BR8806474A (es)
CA (1) CA1330420C (es)
DE (1) DE3851455T2 (es)
ES (1) ES2059507T3 (es)
GB (1) GB8707398D0 (es)
HU (1) HUT52787A (es)
IE (1) IE66732B1 (es)
MY (1) MY103251A (es)
NZ (1) NZ224028A (es)
PH (1) PH31238A (es)
PT (1) PT87080B (es)
WO (1) WO1988007547A1 (es)
ZA (1) ZA882166B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5864008A (en) * 1988-03-25 1999-01-26 James; Stephen Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides
HU210966B (en) * 1988-03-25 1995-09-28 Mallinckrodt Veterinary Inc Method for the preparation of peptides and veterinary compositions containing them
GB8921470D0 (en) * 1989-09-22 1989-11-08 Peptide Technology Ltd Vaccines
US5210180A (en) * 1989-10-27 1993-05-11 American Cyanamid Company Enhancement of porcine somatotropin activity
US6165465A (en) * 1990-05-15 2000-12-26 American Cyanamid Company Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
US5338836A (en) * 1992-07-29 1994-08-16 American Cyanamid Company Biologically active porcine somatotropin polypeptides and methods of using the same
AUPP060097A0 (en) 1997-11-28 1998-01-08 Commonwealth Scientific And Industrial Research Organisation Adjuvant system for enhanced response
AUPP807399A0 (en) * 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
FR2833012B1 (fr) * 2001-12-04 2004-01-30 Centre Nat Rech Scient Peptides agonistes de l'hormone de croissance et leurs applications
PT1463751E (pt) * 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
CN109641936B (zh) * 2016-06-21 2023-11-28 Io生物技术公司 用于癌症疫苗中的pdl1肽
CN112399851A (zh) * 2018-07-11 2021-02-23 俄亥俄大学 基于肽的生长激素作用抑制剂及其使用方法
WO2024107474A1 (en) * 2022-11-15 2024-05-23 Massachusetts Institute Of Technology Controlled lipid self-assembly for scalable manufacturing of next-generation immune stimulating complexes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1011632A1 (ru) * 1981-11-26 1983-04-15 Институт Экспериментальной Эндокринологии И Химии Гормонов Амн Ссср Декапептид, обладающий липотропной активностью
US4699897A (en) * 1983-06-04 1987-10-13 Amgen Biologically active peptides structurally related to regions within growth hormones
US4558033A (en) * 1983-06-06 1985-12-10 Amgen Potentiation of the effects of insulin by peptides

Also Published As

Publication number Publication date
AU622858B2 (en) 1992-04-30
PT87080B (pt) 1992-07-31
HUT52787A (en) 1990-08-28
PH31238A (en) 1998-06-18
PT87080A (pt) 1988-04-01
DE3851455T2 (de) 1995-02-02
KR0134117B1 (ko) 1998-04-14
JPH01502753A (ja) 1989-09-21
ATE111483T1 (de) 1994-09-15
KR890700606A (ko) 1989-04-26
MY103251A (en) 1993-05-29
BR8806474A (pt) 1989-10-31
AU1496888A (en) 1988-11-02
JP2926594B2 (ja) 1999-07-28
EP0284406B1 (en) 1994-09-14
EP0284406A1 (en) 1988-09-28
DE3851455D1 (de) 1994-10-20
GB8707398D0 (en) 1987-04-29
NZ224028A (en) 1990-05-28
ZA882166B (en) 1989-11-29
IE880898L (en) 1988-09-27
CA1330420C (en) 1994-06-28
IE66732B1 (en) 1996-01-24
WO1988007547A1 (en) 1988-10-06

Similar Documents

Publication Publication Date Title
ES2071292T3 (es) Soluciones inyectables estables de factor viii.
ES2159293T3 (es) Analogos de pth y pthrp, su sintesis y uso para el tratamiento de la osteoporosis.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
ES2054020T3 (es) Compuestos biologicamente activos.
DK163930C (da) Biologisk aktivt peptid og peptidfragment deraf med natriuretisk, diuretisk og vasodilataterende aktivitet og terapeutisk middel indeholdende et saadant peptid eller peptidfragment
AR017819A1 (es) Sales de metformina, las composiciones farmaceuticas que las contienen, los metodos terapeuticos que aplican dichos compuestos y las combinaciones de talescompuestos con otros agentes terapeuticos
ES550911A0 (es) Procedimiento para la obtencion de un peptido
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
CY1110927T1 (el) Αμινο-καταληκτικως διακλαδισμενη rantεs ως ανταγωνιστης των χημοκινων
ES460007A1 (es) Procedimiento para la preparacion de nuevas bis (3,5-dicar- bamoil-2,4,6-triyodoanilidas) de acidos dicarboxilicos.
ES2060399T3 (es) Cristales de la hormona del crecimiento y procedimiento para la produccion de estos cristales de la hormona del crecimiento.
ES2083516T3 (es) Preparacion de acidos alcoxialcanoicos.
BR9807618A (pt) Análogo de fator xdelta, dna recombinante codificante para um análogo de fator xdelta, células transformadas, preparação, uso da mesma, e, processos para produzir uma preparação contendo análogo de fator xdelta recombinante purificado e análogo de fator xa.
ATE111483T1 (de) Biologisch wirksame moleküle.
ES2044970T3 (es) Procedimiento para la obtencion de compuestos hidrogenados del acido 1-benzooxacicloalquil-piridincarboxilico.
DK149091C (da) Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf
AR005808A1 (es) Un peptido, usos del mismo, un proceso para prepararlo y una composicion farmaceutica que lo comprende
BR9002009A (pt) Formulacao de aclarador,estavel a armazenagem,processo para sua preparacao e emprego
ES2112921T3 (es) Peptidos y anticuerpos para el tratamiento de la artritis reumatoide.
DK34590D0 (da) Biologisk aktive molekyler
SE8200757L (sv) Biologiskt aktiva peptider
AR018532A1 (es) Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas
ES2084181T3 (es) Composiciones farmaceuticas para usar en el tratamiento del sida.
ES2060650T3 (es) Peptidos de rinovirus humanos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 284406

Country of ref document: ES